Stifel Financial
GSK icon

Stifel Financial’s GSK GSK Stock Holding History

Stifel Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.3M Sell
621,987
-214,207
-26% -$11.6M 0.03% 453
2025
Q4 		$41M Sell
836,194
-48,827
-6% -$2.28M 0.04% 402
2025
Q3 		$38.2M Sell
885,021
-1,805
-0.2% -$70.5K 0.03% 430
2025
Q2 		$34.1M Buy
886,826
+248,883
+39% +$9.51M 0.03% 429
2025
Q1 		$24.7M Buy
637,943
+19,730
+3% +$722K 0.03% 503
2024
Q4 		$20.9M Buy
618,213
+13,240
+2% +$477K 0.02% 559
2024
Q3 		$24.7M Buy
604,973
+53,440
+10% +$2.19M 0.03% 500
2024
Q2 		$21.2M Sell
551,533
-32,120
-6% -$1.35M 0.02% 519
2024
Q1 		$25M Sell
583,653
-53,752
-8% -$2.22M 0.03% 467
2023
Q4 		$23.6M Sell
637,405
-52,801
-8% -$1.9M 0.03% 454
2023
Q3 		$25M Sell
690,206
-41,536
-6% -$1.47M 0.04% 412
2023
Q2 		$26.1M Buy
731,742
+5,988
+0.8% +$215K 0.04% 395
2023
Q1 		$25.8M Buy
725,754
+71,737
+11% +$2.51M 0.04% 393
2022
Q4 		$23M Buy
654,017
+29,540
+5% +$984K 0.03% 416
2022
Q3 		$18.4M Buy
624,477
+65,883
+12% +$2.5M 0.03% 451
2022
Q2 		$30.4M Buy
558,594
+34,031
+6% +$1.88M 0.05% 333
2022
Q1 		$28.6M Buy
524,563
+22,840
+5% +$1.24M 0.04% 390
2021
Q4 		$27.7M Buy
501,723
+19,529
+4% +$1.02M 0.04% 401
2021
Q3 		$23M Buy
482,194
+76,576
+19% +$3.85M 0.03% 442
2021
Q2 		$20.2M Sell
405,618
-139,209
-26% -$6.69M 0.03% 463
2021
Q1 		$24.3M Buy
544,827
+43,221
+9% +$1.96M 0.04% 367
2020
Q4 		$23.1M Sell
501,606
-76,147
-13% -$3.5M 0.04% 360
2020
Q3 		$27.2M Buy
577,753
+83,239
+17% +$4.17M 0.06% 294
2020
Q2 		$25.2M Sell
494,514
-53,373
-10% -$2.74M 0.06% 279
2020
Q1 		$26M Sell
547,887
-162,154
-23% -$8.65M 0.07% 246
2019
Q4 		$41.7M Buy
710,041
+20,066
+3% +$1.12M 0.09% 226
2019
Q3 		$36.8M Sell
689,975
-2,642
-0.4% -$136K 0.09% 218
2019
Q2 		$34.6M Buy
692,617
+135,758
+24% +$6.81M 0.09% 224
2019
Q1 		$29.1M Sell
556,859
-96,734
-15% -$4.83M 0.08% 240
2018
Q4 		$31.2M Sell
653,593
-7,589
-1% -$374K 0.1% 212
2018
Q3 		$33.2M Sell
661,182
-381
-0.1% -$19.4K 0.1% 214
2018
Q2 		$33.3M Sell
661,563
-18,120
-3% -$913K 0.1% 205
2018
Q1 		$33.2M Buy
679,683
+37,717
+6% +$1.76M 0.1% 199
2017
Q4 		$28.5M Sell
641,966
-86,310
-12% -$3.99M 0.09% 236
2017
Q3 		$36.9M Sell
728,276
-6,090
-0.8% -$309K 0.13% 180
2017
Q2 		$39.6M Sell
734,366
-46,744
-6% -$2.49M 0.15% 159
2017
Q1 		$41.2M Buy
781,110
+68,036
+10% +$3.45M 0.16% 149
2016
Q4 		$34.4M Sell
713,074
-79,990
-10% -$3.95M 0.15% 164
2016
Q3 		$42.8M Buy
793,064
+359,567
+83% +$19.7M 0.19% 122
2016
Q2 		$23.5M Buy
433,497
+61,256
+16% +$3.23M 0.11% 199
2016
Q1 		$18.9M Buy
372,241
+9,850
+3% +$491K 0.1% 221
2015
Q4 		$18.3M Sell
362,391
-558,296
-61% -$28.5M 0.1% 230
2015
Q3 		$44.2M Buy
920,687
+24,482
+3% +$1.27M 0.25% 104
2015
Q2 		$46.5M Buy
896,205
+49,699
+6% +$2.8M 0.24% 108
2015
Q1 		$48.8M Buy
846,506
+66,346
+9% +$3.8M 0.27% 86
2014
Q4 		$41.7M Buy
780,160
+40,907
+6% +$2.29M 0.23% 105
2014
Q3 		$42.5M Buy
739,253
+246,594
+50% +$15.1M 0.37% 48
2014
Q2 		$32.9M Buy
492,659
+39,905
+9% +$2.7M 0.3% 62
2014
Q1 		$30.3M Buy
+452,754
New +$30.6M 0.29% 68

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stifel Financial's GSK Position: Q1 2026 in Review

Stifel Financial reduced its GSK (GSK) stake by 26% in Q1 2026, selling an estimated $11.6M and leaving 621,987 shares worth $34.3M. The position accounts for 0.03% of the portfolio, ranked #453.

Stifel Financial first reported a position in GSK in Q1 2014 and has held it in 49 quarters since. The position peaked at $48.8M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Stifel Financial held 621,987 shares of GSK worth $34.3M as of Q1 2026.
  • Stifel Financial sold 214,207 GSK shares in Q1 2026, an estimated $11.6M.
  • GSK made up 0.03% of Stifel Financial's portfolio in Q1 2026, its #453 holding.
  • Stifel Financial first reported a position in GSK in Q1 2014 and has held it in 49 quarters since.
  • Stifel Financial's GSK position peaked at $48.8M in Q1 2015.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.